Fig. 1 · Structure
Documents & Downloads
PBI-1393
Anticancer Agent
PBI-1393 (BCH-1393) is an anticancer agent that promotes Th1-type cytokine production and enhances primary T cell activation. This compound plays a significant role in modulating immune responses, making it a valuable tool for research in cancer immunotherapy and immune system studies. Its ability to stimulate T cell activity positions it as a promising candidate for investigating novel therapeutic strategies in oncological research.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 175072-12-5 |
| Applications | Anticancer Agent |
| Formula | C19H31N9O4 |
| Molecular Weight | 449.51 |
| Synonyms | BCH-1393 |
| SMILES | N=C(NCCC[C@@H](NC(OCCCCCN1C=NC2=C(N=CN=C12)N(C)C)=O)C(O)=O)N |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.